A new treatment has been identified for the post-infection of Covid 19

A new treatment has been identified for the post-infection of Covid 19

WASHINGTON: Scientists have identified a post-infection treatment for stork cove 2, a virus that causes cove 19, and has successfully demonstrated its effectiveness in preventing viral reproduction in mice.
The study, published in the Journal Proceedings of the National Academy of Sciences, found that animal models infected with SARS-Co-2 and treated with inhibitors of protease enzymes had significantly increased survival and viral lung disease. The quantity was reduced.
These protease inhibitors are a class of antiviral drugs that inhibit viral reproduction by selectively binding to viral enzymes and inhibiting the activity of proteins necessary for the production of infectious viral particles.
“We developed the lactase protease inhibitor GC376 to treat a deadly coronavirus infection in cats, which is now in commercial development as a new investigative veterinary drug,” said Yunjing Kim, an associate professor at Kansas State University in the United States. ۔ ”
“Since the emergence of Covid-19, many research groups have reported that this inhibitor is also effective against the corona virus that causes Covid-19, and many people are currently receiving treatment,” Kim said. Prostheses are in the process of developing inhibitors. ”
The research team modified GC376 using a tool called Detoxification to test its effectiveness against SARS-Co-2.
Researchers say that treatment with a rugged change that began 24 hours after the integration did not result in a significant increase in the recovery of mice compared to untreated mice.
“The results show that there is excellent potential as an antiviral agent against saris-ko-2 in adverse conditions,” he said.
“Significantly improved survival, viral replication in the lungs and weight loss with the paralyzed GC376 in mice infected with SARS Covey-2,” said Keung Okchang, a professor at Cancer State University, adding to the effectiveness of the antiviral compound. Appears.
“The results show that the uncoupled GC376 has the potential for further development, and this degradation mechanism can be used in other antiviral compounds to produce force inhibitors,” Chang said.
Expert viruses continue to develop better inhibitors using a variety of methods. The postmodern GC376 is currently being tested for further development.

STAY TUNED WITH US FOR MORE INTERESTING CONTENT ONLY ON DESINEW.XYZ

Leave a Reply

Your email address will not be published. Required fields are marked *